Floatz logo

FLURBIPROFEN

Radiculopathy

Express Specialty PharmacySmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Radiculopathy cohort.

Asset / SponsorPhaseRating
Triamcinalone
University of Miami
Phase 4BBB
LIDOCAINE
Sheba Medical Center
Phase 4BBB
sp-102
Semnur Pharmaceuticals, Inc.
Phase 3BB
DEXAMETHASONE
Semnur Pharmaceuticals, Inc.
Phase 4BB
Celestone
Sheba Medical Center
Phase 4BB

View all 37 →

Same molecule, other indications

FLURBIPROFEN is also rated in:

Healthy Adult ParticipantsDormant
CC
Indicative ·
47 / 100
View asset →
Leukemia, Myeloid, AcuteDormant
CC
Indicative ·
44 / 100
View asset →
sickle cell diseaseDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →